C4 Therapeutics, Inc. (CCCC) SEC filings
CCCC SEC filings moved a median of -1.65% by the close. CCCC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CCCC overview →
69 measured CCCC SEC filing events.
Where these CCCC SEC filings landedvs 69 measured CCCC SEC filing reactions
| Middle 50% of CCCC SEC filing reactions | -5.56% to +2.39% |
|---|---|
| Median reaction (to close) | -1.65% |
| Measured reactions | 69 |
Point-in-time · zero look-ahead
Half of the 69 CCCC SEC filing events with a measured close landed between -5.56% and +2.39%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K C4 Therapeutics, Inc. For: Sep 25 | SEC filing · Form 8-K | +1.65% | -1.65% | |
| Form 10-Q C4 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.04% | +0.78% | |
| Form 8-K C4 Therapeutics, Inc. For: Aug 11 | SEC filing · Form 8-K | -4.04% | +0.78% | |
| Form 8-K C4 Therapeutics, Inc. For: Jun 24 | SEC filing · Form 8-K | +2.00% | +3.77% | |
| Form 8-K C4 Therapeutics, Inc. For: Jun 11 | SEC filing · Form 8-K | -1.44% | +1.31% | |
| Form 8-K C4 Therapeutics, Inc. For: May 15 | SEC filing · Form 8-K | -0.85% | -8.78% | |
| Form 10-Q C4 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.16% | +2.92% | |
| Form 8-K C4 Therapeutics, Inc. For: May 12 | SEC filing · Form 8-K | +0.16% | +2.92% | |
| Form ARS C4 Therapeutics, Inc. For: Apr 29 | SEC filing · Form ARS | -1.82% | -6.57% | |
| Form DEF 14A C4 Therapeutics, Inc. For: Apr 29 | SEC filing · Form DEF | -1.82% | -6.57% | |
| Form DEFA14A C4 Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.82% | -6.57% | |
| Form 8-K C4 Therapeutics, Inc. For: Apr 10 | SEC filing · Form 8-K | -2.82% | -10.74% | |
| Form 8-K C4 Therapeutics, Inc. For: Apr 09 | SEC filing · Form 8-K | -1.66% | +0.00% | |
| Form 10-K C4 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.45% | -2.80% | |
| Form 8-K C4 Therapeutics, Inc. For: Feb 26 | SEC filing · Form 8-K | -2.45% | -2.80% | |
| Form S-8 C4 Therapeutics, Inc. | SEC filing · Form S-8 | -2.45% | -2.80% | |
| Form 8-K C4 Therapeutics, Inc. For: Jan 14 | SEC filing · Form 8-K | +4.31% | +0.43% | |
| Form EFFECT C4 Therapeutics, Inc. | SEC filing · Form EFFECT | +0.58% | -1.55% | |
| Form S-3 C4 Therapeutics, Inc. | SEC filing · Form S-3 | +2.50% | +2.50% | |
| Form 10-Q C4 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.28% | |
| Form 8-K C4 Therapeutics, Inc. For: Nov 06 | SEC filing · Form 8-K | +0.00% | +1.28% | |
| Form 8-K C4 Therapeutics, Inc. For: Oct 16 | SEC filing · Form 8-K | +4.84% | +16.98% | |
| Form 8-K C4 Therapeutics, Inc. For: Oct 01 | SEC filing · Form 8-K | +2.24% | -3.59% | |
| Form 8-K C4 Therapeutics, Inc. For: Sep 22 | SEC filing · Form 8-K | +2.12% | -20.91% | |
| Form 10-Q C4 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.75% | +29.00% | |
| Form 8-K C4 Therapeutics, Inc. For: Aug 07 | SEC filing · Form 8-K | +0.75% | +29.00% | |
| Form 8-K C4 Therapeutics, Inc. For: Jun 18 | SEC filing · Form 8-K | -0.66% | -2.07% | |
| Form 10-Q C4 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.85% | -3.85% | |
| Form 8-K C4 Therapeutics, Inc. For: May 07 | SEC filing · Form 8-K | -3.85% | -3.85% | |
| Form ARS C4 Therapeutics, Inc. For: Apr 29 | SEC filing · Form ARS | -1.55% | -1.86% | |
| Form DEF 14A C4 Therapeutics, Inc. For: Apr 29 | SEC filing · Form DEF | -1.55% | -1.86% | |
| Form DEFA14A C4 Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.55% | -1.86% | |
| Form PRE 14A C4 Therapeutics, Inc. For: Apr 16 | SEC filing · Form PRE | +2.12% | -6.78% | |
| Form 8-K C4 Therapeutics, Inc. For: Apr 14 | SEC filing · Form 8-K | -0.03% | -1.60% | |
| Form 10-K C4 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.38% | -1.14% | |
| Form 8-K C4 Therapeutics, Inc. For: Feb 27 | SEC filing · Form 8-K | +0.38% | -1.14% | |
| Form S-8 C4 Therapeutics, Inc. | SEC filing · Form S-8 | +0.38% | -1.14% | |
| Form 8-K C4 Therapeutics, Inc. For: Jan 14 | SEC filing · Form 8-K | +2.53% | +5.06% | |
| Form 8-K C4 Therapeutics, Inc. For: Dec 09 | SEC filing · Form 8-K | +1.16% | -3.01% | |
| Form 8-K C4 Therapeutics, Inc. For: Nov 20 | SEC filing · Form 8-K | -3.36% | -2.88% | |
| Form EFFECT C4 Therapeutics, Inc. | SEC filing · Form EFFECT | -1.95% | -8.17% | |
| Form SUPPL C4 Therapeutics, Inc. | SEC filing · Form SUPPL | -1.95% | -8.17% | |
| Form 10-Q C4 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.58% | -6.16% | |
| Form 8-K C4 Therapeutics, Inc. For: Oct 31 | SEC filing · Form 8-K | -4.58% | -6.16% | |
| Form S-3 C4 Therapeutics, Inc. | SEC filing · Form S-3 | -0.18% | +0.36% | |
| Form 8-K/A C4 Therapeutics, Inc. For: Oct 15 | SEC filing · Form 8-K | +2.54% | +11.29% | |
| Form 8-K C4 Therapeutics, Inc. For: Oct 15 | SEC filing · Form 8-K | +2.54% | +11.29% | |
| Form 8-K C4 Therapeutics, Inc. For: Oct 11 | SEC filing · Form 8-K | +0.91% | +7.10% | |
| Form 8-K C4 Therapeutics, Inc. For: Sep 03 | SEC filing · Form 8-K | -1.12% | -3.69% | |
| Form 10-Q C4 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.14% | -3.05% | |
| Form 8-K C4 Therapeutics, Inc. For: Aug 01 | SEC filing · Form 8-K | +0.14% | -3.05% | |
| Form 8-K C4 Therapeutics, Inc. For: Jun 21 | SEC filing · Form 8-K | +1.88% | +10.82% | |
| Form 8-K C4 Therapeutics, Inc. For: Jun 10 | SEC filing · Form 8-K | -0.98% | +5.24% | |
| Form 10-Q C4 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.17% | -5.56% | |
| Form 8-K C4 Therapeutics, Inc. For: May 08 | SEC filing · Form 8-K | -1.17% | -5.56% | |
| Form ARS C4 Therapeutics, Inc. For: Apr 30 | SEC filing · Form ARS | -0.16% | +1.29% | |
| Form DEF 14A C4 Therapeutics, Inc. For: Apr 29 | SEC filing · Form DEF | +2.09% | +1.45% | |
| Form DEFA14A C4 Therapeutics, Inc. | SEC filing · Form DEFA14A | +2.09% | +1.45% | |
| Form 8-K C4 Therapeutics, Inc. For: Mar 08 | SEC filing · Form 8-K | +3.50% | -3.28% | |
| Form 8-K C4 Therapeutics, Inc. For: Mar 04 | SEC filing · Form 8-K | -5.06% | -9.87% | |
| Form 10-K C4 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.66% | +21.38% | |
| Form 8-K C4 Therapeutics, Inc. For: Feb 22 | SEC filing · Form 8-K | +1.66% | +21.38% | |
| Form S-8 C4 Therapeutics, Inc. | SEC filing · Form S-8 | +1.66% | +21.38% | |
| Form 8-K C4 Therapeutics, Inc. For: Jan 11 | SEC filing · Form 8-K | -2.73% | -5.73% | |
| Form 8-K C4 Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | +7.18% | +2.39% | |
| Form 8-K C4 Therapeutics, Inc. For: Dec 12 | SEC filing · Form 8-K | -0.55% | +28.57% | |
| Form 8-K C4 Therapeutics, Inc. For: Nov 20 | SEC filing · Form 8-K | -3.24% | -8.65% | |
| Form 10-Q C4 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.94% | -18.52% | |
| Form 8-K C4 Therapeutics, Inc. For: Nov 01 | SEC filing · Form 8-K | -4.94% | -18.52% |
Keep exploring
More CCCC: earnings → · analyst actions → · CCCC overview →